IP Library Granted Patent US 9,415,233
Granted Patent B2
US 9,415,233 · App. 14/171,644 · Granted Aug 16, 2016

Apparatus and method for electromagnetic treatment of neurological pain

Inventors: Arthur A. Pilla (Oakland, NJ); Andre' A. DiMino (Woodcliff Lake, NJ); Iyer Viswanathan (Santa Clara, CA); Diana Casper (New York, NY); Berish Strauch (Rye, NY)
Assignee: Rio Grande Neurosciences, Inc.
A61N2/008A61N1/36014A61N2/006A61N1/36025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,415,233
App. No.
14/171,644
Granted
Aug 16, 2016
Kind
B2
Abstract

Described herein are methods of treating neurological injury and conditions, in particular neurological pain. These treatment methods can include the steps of generating a pulsed electromagnetic field from a pulsed electromagnetic field source and applying the pulsed electromagnetic field in proximity to a target region.

Claims (59)

1. A method for treating a neurological pain in a patient in need thereof, the method comprising:

generating a pulsed electromagnetic field from a portable pulsed electromagnetic field source, the pulsed electromagnetic field having a peak amplitude of less than 200 milliGauss and wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

externally applying the pulsed electromagnetic field through a skull to a target region affected by the neurological pain; and

reducing the neurological pain or a physiological response to the neurological pain by externally applying the pulsed electromagnetic field.

2. The method of claim 1 , wherein reducing a physiological response by applying the pulsed electromagnetic field includes reducing inflammation in the target region.

3. The method of claim 1 , wherein the physiological response is neuronal degeneration.

4. The method of claim 1 , wherein the physiological response is inflammation.

5. The method of claim 1 , wherein the physiological response is increased intracranial pressure.

6. The method of claim 1 , further comprising

monitoring the physiological response; and

continuing to apply the pulsed electromagnetic field until an acceptable level of the physiological response is reached.

7. The method of claim 6 , wherein the physiological response is increased intracranial pressure and the acceptable level is below about 20 mmHg.

8. The method of claim 1 , wherein generating the pulsed electromagnetic field comprises a 2 msec burst of 27.12 MHz sinusoidal waves repeating at 2 Hz.

9. The method of claim 1 , wherein the pulsed electromagnetic field comprises a 3 msec burst of 27.12 MHz sinusoidal waves repeating at 2 Hz.

10. The method of claim 1 , wherein the pulsed electromagnetic field comprises a 4 msec burst of 27.12 MHz sinusoidal waves repeating at 2 Hz.

11. The method of claim 1 , wherein the pulsed electromagnetic field comprises about a 1 msec to about a 10 msec burst of 27.12 MHz sinusoidal waves repeating at about 1 Hz to about 10 Hz.

12. The method of claim 1 , wherein the pulsed electromagnetic field comprises an ISM carrier frequency modulated at about a 1 msec to about a 10 msec burst repeating at about 1 Hz to about 10 Hz.

13. The method of claim 1 , wherein the physiological system is the central nervous system.

14. The method of claim 1 , wherein the electromagnetic field comprises a waveform that modulates at least one biological signaling pathway.

15. The method of claim 1 , wherein the target region is a brain of the patient.

16. A method for treating a neurological pain in a patient in need thereof, the method comprising:

generating a first pulsed electromagnetic field from a pulsed electromagnetic field source, the first pulsed electromagnetic field having a peak amplitude of less than 200 milliGauss and wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

externally applying the first pulsed electromagnetic field through a skull to a target region affected by the neurological pain for a first treatment interval;

reducing the neurological pain or a physiological response to the neurological pain by externally applying the first pulsed electromagnetic field;

discontinuing the application of the first pulsed electromagnetic field for an inter-treatment period greater than zero; and

externally applying a second pulsed electromagnetic field to the target region wherein the second pulsed electromagnetic field has a peak amplitude of less than 200 milliGauss and wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz.

17. The method of claim 16 , wherein reducing a physiological response by applying the first pulsed electromagnetic field includes reducing inflammation in the target region.

18. The method of claim 16 , wherein the physiological response is neuronal degeneration.

19. The method of claim 16 , wherein the first and second pulsed electromagnetic fields are substantially the same.

20. The method of claim 16 , further comprising

monitoring the physiological response; and

modifying the first pulsed electromagnetic field to the second pulsed electromagnetic field in response to the monitoring step.

21. The method of claim 16 , further comprising

monitoring the physiological response; and

discontinuing treatment once an acceptable level of the physiological response is reached.

22. The method of claim 16 , further comprising attenuating inflammatory cytokines and growth factors at the target region by applying the first pulsed electromagnetic field or the second pulsed electromagnetic field to the target region.

23. The method of claim 16 , further comprising accelerating the healing of the target region by applying the first pulsed electromagnetic field or the second pulsed electromagnetic field to the target region.

24. The method of claim 16 , wherein applying the first pulsed electromagnetic field in proximity to a target region affected by the neurological pain to reduce a physiological response comprises reducing a concentration of IL-1β.

25. The method of claim 16 , further comprising increasing a growth factor in the target region.

26. The method of claim 25 , wherein increasing a growth factor in the target region enhances angiogenesis.

27. The method of claim 25 , wherein increasing a growth factor in the target region enhances nervous tissue regeneration.

28. The method of claim 25 , wherein the growth factor is selected from the group consisting of FGF-2, VEGF, and BMP.

29. The method of claim 16 , wherein the target region is a brain of the patient.

30. A method for treating a neurological pain in a patient in need thereof, the method comprising:

generating a pulsed electromagnetic field from a pulsed electromagnetic field source, the pulsed electromagnetic field having a peak amplitude of less than 200 milliGauss and wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

externally applying the pulsed electromagnetic field through a skull to a target brain region affected by the neurological pain; and

modulating microglia activation in the target brain region and reducing the neurological pain or a physiological response to the neurological pain by externally applying the pulsed electromagnetic field.

31. The method of claim 30 , wherein reducing a physiological response by applying the pulsed electromagnetic field includes reducing inflammation in the target region.

32. The method of claim 30 , wherein the physiological response is neuronal degeneration.

33. The method of claim 30 , wherein modulating microglia activation comprises reducing microglia activation in the target brain region.

34. A method of promoting neurological repair or growth to treat a neurological pain comprising:

placing a treatment coil of a self-contained, lightweight, and portable treatment apparatus externally through a skull to a target treatment site in need of treatment, wherein the treatment apparatus comprises a conformable coil having one or more turns of wire and a control circuit;

generating an electromagnetic field using the treatment coil, the electromagnetic field having a peak amplitude of less than 200 milliGauss and wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

delivering the electromagnetic field to the target treatment site using the treatment coil; and

reducing the neurological pain or a physiological response to the neurological pain by delivering the electromagnetic field.

35. The method of claim 34 , wherein reducing a physiological response by delivering the electromagnetic field to the target treatment site includes reducing inflammation in the target treatment site.

36. The method of claim 34 , wherein the physiological response is neuronal degeneration.

37. The method of claim 34 , further comprising delivering the electromagnetic field for a period of about 1 minute to about 240 minutes.

38. The method of claim 34 , wherein the target treatment site is a brain.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2024
From: ENDONOVO THERAPEUTICS, INC.
To: SOFPULSE, INC.
Reel/Frame 067933/0673 →
LICENSE Recorded Sep 24, 2019
From: RIO GRANDE NEUROSCIENCES, INC., ASSIGNOR TO ENDONOVO THERAPEUTICS INC.
To: AAH HOLDINGS LLC
Reel/Frame 050475/0809 →
SECURITY AGREEMENT Recorded Feb 1, 2018
From: ENDONOVO THERAPEUTICS, INC.
To: STEVEN M. GLUCKSTERN
Reel/Frame 045221/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2018
From: RIO GRANDE NEUROSCIENCES, INC.
To: ENDONOVO THERAPEUTICS INC.
Reel/Frame 044644/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2016
From: IVIVI HEALTH SCIENCES, LLC
To: RIO GRANDE NEUROSCIENCES, INC.
Reel/Frame 037445/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: IVIVI HEALTH SCIENCES, LLC
To: RIO GRANDE NEUROSCIENCES, INC.
Reel/Frame 037394/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2014
From: PILLA, ARTHUR A.; DIMINO, ANDRE' A.; VISWANATHAN, IYER; CASPER, DIANA; STRAUCH, BERISH
To: IVIVI HEALTH SCIENCES, LLC
Reel/Frame 034094/0071 →
Continuity (25)
Continuation In Part 13252114 · Oct 3, 2011
Continuation In Part 13801789 · Mar 13, 2013
Continuation 12819956 · Jun 21, 2010
Continuation In Part 12772002 · Apr 30, 2010
Continuation 11003108 · Dec 3, 2004
Continuation In Part 11114666 · Apr 26, 2005
Continuation In Part 11110000 · Apr 19, 2005
Continuation In Part 11369308 · Mar 6, 2006
Continuation In Part 11369309 · Mar 6, 2006
Continuation In Part 11223073 · Sep 10, 2005
Continuation In Part 11339204 · Jan 25, 2006
Continuation In Part 11818065 · Jun 12, 2007
Continuation In Part 11903294 · Sep 20, 2007
Continuation In Part 11977043 · Oct 22, 2007
Provisional Application 61389038 · Oct 1, 2010
Provisional Application 61456310 · Nov 4, 2010
Provisional Application 60527327 · Dec 5, 2003
Provisional Application 60564887 · Apr 26, 2004
Provisional Application 60563104 · Apr 19, 2004
Provisional Application 60658967 · Mar 7, 2005
Provisional Application 60658968 · Mar 7, 2005
Provisional Application 60812841 · Jun 12, 2006
Provisional Application 60846126 · Sep 20, 2006
Provisional Application 60852927 · Oct 20, 2006
Related Publication 20140213844A1 · Jul 31, 2014